Alkermes Investigational Site is a clinical research site located in Canton, Ohio, United States 44718.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Alkermes Investigational Site has participated in 13 clinical trials with 1 currently active.
Therapeutic areas: Major Depressive Disorder, Schizophrenia, Schizophreniform Disorder.
Sponsors: Alkermes, Inc., Biogen.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Alkermes Investigational Site has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Alkermes Investigational Site has 13 clinical trials on record, with 1 currently active. Their work covers Major Depressive Disorder, Schizophrenia, Schizophreniform Disorder.
Yes — Alkermes Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.